Skip to content
HowShorted

Quince Therapeutics, Inc. short interest in 2019

In 2019, Quince Therapeutics, Inc.'s disclosed short interest ran from 2.09% of shares outstanding on 15 Oct 2019 to 5.77% on 31 Dec 2019, a change of +3.68 percentage points. The year's high was 5.77% on 31 Dec 2019 and its low 2.09% on 15 Oct 2019, averaging 3.20% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 31.90 days on 15 Oct 2019. Full history: Quince Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Quince Therapeutics, Inc. in 2019

2019 in figures

Start of year
2.09% (15 Oct 2019)
End of year
5.77% (31 Dec 2019)
Change
+3.68 pp
High
5.77% (31 Dec 2019)
Low
2.09% (15 Oct 2019)
Average
3.20%
Highest days to cover
31.90 (15 Oct 2019)
SEC filings marked
3

Every report in 2019

Quince Therapeutics, Inc. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Oct 20192.09%31.9010-Q filed, 10-Q filed
31 Oct 20192.29%23.41
15 Nov 20192.48%12.1310-Q filed
29 Nov 20192.45%6.63
13 Dec 20194.14%4.64
31 Dec 20195.77%4.46

See also: Quince Therapeutics, Inc.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.